RAP
Click for more information
0.00% 20.5¢ resapp health limited

Ann: IRB approval for US COVID-19 study modification, page-20

  1. Mcfisty
    272 Posts.
    lightbulb Created with Sketch. 52
    clock Created with Sketch.
    16/11/21
    01:57
    Post #: 57598390
    They won’t get any regulatory approval without clinical data, and the results need to be positive. I don’t think they have announced whether they will use the emergency authorisation pathway, but they would be crazy not to.
    RAP Price at posting: 5.3¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.